↓ Skip to main content

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined…

Overview of attention for article published in Trials, June 2019
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
Published in
Trials, June 2019
DOI 10.1186/s13063-019-3409-1
Pubmed ID
Authors

Wesley de Jong, Joeri Aerts, Sabine Allard, Christian Brander, Jozefien Buyze, Eric Florence, Eric van Gorp, Guido Vanham, Lorna Leal, Beatriz Mothe, Kris Thielemans, Montse Plana, Félipe Garcia, Rob Gruters

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 16%
Researcher 10 11%
Student > Master 10 11%
Other 6 7%
Student > Bachelor 5 6%
Other 9 10%
Unknown 35 39%
Readers by discipline Count As %
Medicine and Dentistry 13 15%
Immunology and Microbiology 10 11%
Biochemistry, Genetics and Molecular Biology 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 8 9%
Nursing and Health Professions 5 6%
Other 10 11%
Unknown 34 38%